Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-25-022861

Chief Executive Officer sold 16,800 shares at $40.00 ($672,020)

  • Chief Executive Officer acquired 16,800 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Robinson Chandler · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-07-14 Option exercise : show line 1 in the form +16,800 $0.01 $84 90,272 D
2025-07-14 Sale : show line 2 in the form −16,800 $40.00 $672,020 73,472 D
Open-market sales · 16,800 sh · avg $40.00 · $672,020

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-07-14 Option exercise : show line 3 in the form Stock Options −16,800 0 D
Loading xslF345X05/rdgdoc.xml…